NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 7 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 76,109 | $11,040 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CLEAR STREET LLC | 59,272 | $9 | 0.00% |
| Hudson Bay Capital Management LP | 173,506 | $27,760 | 0.00% |
| Citadel Advisors | 11,588 | $1,854 | 0.00% |
| UBS Group AG | 3,802 | $422 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 200 | $22 | 0.00% |
This page lists NEUROSENSE THERAPEUTICS LTD's shareholders in Q3 2023. To view NEUROSENSE THERAPEUTICS LTD's shareholder history, click here.